Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02511769 · ClinicalTrials.gov registry record · NA
Web-MAP Intervention for Youth With Sickle Cell Disease
A NA study, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02511769 is a NA study that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 42 participants.
The verdict
NCT02511769, a NA study, has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The proposed study will determine whether the efficacy of WebMAP cognitive behavioral therapy (CBT) treatment study generalizes to pediatric sickle cell disease (SCD), and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment from sickle cell centers will also be determined. The short-term goal is to produce preliminary data to apply for an R01 proposal to carry out a multi-institutional randomized controlled trial (RCT) of internet-delivered behavioral intervention in a large population of youth with SCD. The long-term goal of this research is to develop effective, easily accessible, behavioral pain interventions for youth with SCD to reduce the long-term impact of pain on function, quality of life, and health service use in this population. The design of this study is an experimental 2 (group) x 3 (time of measurement) randomized controlled trial design to test the acceptability and efficacy of the Web-MAP intervention in reducing pain and functional impairment in youth with sickle cell disease. (Figure 1) Subjects will be randomized to either the behavioral intervention or the online patient education control group. The treatment protocol will be implemented over 8 weeks in Internet-based treatment modules. The primary study outcome is pain and functional impairment measured at baseline, immediately post-treatment, and at 3-month follow-up.
Interventions
- BEHAVIORAL WEB-MAP Educational Control Group
- BEHAVIORAL WEB-MAP CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2013-09 |
| Est. Completion | 2016-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02511769
The ClinicalTrials.gov registry entry for NCT02511769 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which WEB-MAP Educational Control Group is the first listed.
NCT02511769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02511769 about?
NCT02511769 is a clinical study titled "Web-MAP Intervention for Youth With Sickle Cell Disease". The proposed study will determine whether the efficacy of WebMAP cognitive behavioral therapy (CBT) treatment study generalizes to pediatric sickle cell disease (SCD), and explore whether the intervention is feasible and acceptable to this population. Feasibility of multi-institutional recruitment f...
What is the current status of trial NCT02511769?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2013-09. Estimated completion is 2016-08-18.
What interventions are being tested in trial NCT02511769?
The interventions under investigation include: WEB-MAP Educational Control Group (BEHAVIORAL), WEB-MAP CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02511769?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.